Journal of Clinical Oncology · 2016 · 245 citations · 17 references
MedicineOncologySurgerySurgical OncologySurvival AnalysisThoracic OncologyCancer StagingCancer Survival AnalysisLung CancerPulmonary ResectionThoracic SurgeryTumor StagingAnatomic SegmentectomyLung Cancer ResectionLung Cancer StagingPrognostic Factors AnalysisSublobar ResectionWedge Resection
PURPOSE: According to the lung cancer staging project, T1a (≤ 2 cm) non-small-cell lung cancer (NSCLC) should be additionally classified into ≤ 1 cm and > 1 to 2 cm groups. This study aimed to investigate the surgical procedure for NSCLC ≤ 1 cm and > 1 to 2 cm. METHODS: We identified 15,760 patients with T1aN0M0 NSCLC after surgery from the Surveillance, Epidemiology, and End Results database. Overall survival (OS) and lung cancer-specific survival (LCSS) were compared among patients after lobectomy, segmentectomy, or wedge resection. The proportional hazards model was applied to evaluate multiple prognostic factors. RESULTS: OS and LCSS favored lobectomy compared with segmentectomy or wedge resection in patients with NSCLC ≤ 1 cm and > 1 to 2 cm. Multivariable analysis showed that segmentectomy and wedge resection were independently associated with poorer OS and LCSS than lobectomy for NSCLC ≤ 1 cm and > 1 to 2 cm. With sublobar resection, lower OS and LCSS emerged for NSCLC > 1 to 2 cm after wedge resection, whereas similar survivals were observed for NSCLC ≤ 1 cm. Multivariable analyses showed that wedge resection is an independent risk factor of survival for NSCLC > 1 to 2 cm but not for NSCLC ≤ 1 cm. CONCLUSION: Lobectomy showed better survival than sublobar resection for patients with NSCLC ≤ 1 cm and > 1 to 2 cm. For patients in whom lobectomy is unsuitable, segmentectomy should be recommended for NSCLC > 1 to 2 cm, whereas surgeons could rely on surgical skills and the patient profile to decide between segmentectomy and wedge resection for NSCLC ≤ 1 cm.
17
Ramón Rami–Porta, Vanessa Bolejack, John Crowley et al. · Journal of Thoracic Oncology · 2015 · 774 citations · Full text
Jung‐Jyh Hung, Yi‐Chen Yeh, Wen-Juei Jeng et al. · Journal of Clinical Oncology · 2014 · 261 citations